• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Properdin factor D: characterization of its active site and isolation of the precursor form.备解素因子D:其活性位点的表征及前体形式的分离。
J Exp Med. 1974 Feb 1;139(2):355-66. doi: 10.1084/jem.139.2.355.
2
Properdin: initiation of alternative complement pathway.备解素:替代补体途径的起始因子
Proc Natl Acad Sci U S A. 1975 Aug;72(8):3220-4. doi: 10.1073/pnas.72.8.3220.
3
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.备解素:与C3b结合并稳定依赖C3b的C3转化酶。
J Exp Med. 1975 Oct 1;142(4):856-63. doi: 10.1084/jem.142.4.856.
4
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.补体替代途径:不稳定的C3/C5转化酶招募前体备解素并增强该途径。
J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076.
5
Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.在C3肾炎因子(C3NeF)存在的情况下,形成含有未裂解B的替代途径C3转化酶。
Immunology. 1976 Nov;31(5):789-96.
6
Properdin factor D. II. Activation to D by properdin.备解素因子D。二、备解素将其激活为D。
J Exp Med. 1974 Aug 1;140(2):426-36. doi: 10.1084/jem.140.2.426.
7
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.由于酵母聚糖结合的扩增转化酶对内源调节机制具有抗性,导致替代补体途径激活。
Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7. doi: 10.1073/pnas.74.4.1683.
8
Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.由备解素途径的D因子和B因子与眼镜蛇毒因子或C3B相互作用产生的趋化活性。
J Clin Invest. 1975 Mar;55(3):587-92. doi: 10.1172/JCI107966.
9
Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.备解素因子B和D与补体激活的第三成分相互作用形成具有溶血活性的细胞中间体。
J Exp Med. 1973 Dec 1;138(6):1305-13. doi: 10.1084/jem.138.6.1305.
10
Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.通过规避内源性控制蛋白的调节作用,利用兔红细胞激活替代补体途径。
J Exp Med. 1977 Jul 1;146(1):22-33. doi: 10.1084/jem.146.1.22.

引用本文的文献

1
Chronic kidney disease enhances alternative pathway activity: a new paradigm.慢性肾脏病增强替代途径活性:一种新范式。
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188353.
2
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.靶向补体介导疾病中的替代和凝集素途径成分的策略。
Front Immunol. 2018 Aug 8;9:1851. doi: 10.3389/fimmu.2018.01851. eCollection 2018.
3
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径:C3 和 C5 激活的“替代激活途径”还是“关键扩增环”?
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
4
C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.C3 调控异常是由于补体因子 H 缺乏,这在体内与甘露聚糖结合凝集素相关丝氨酸蛋白酶(MASP)-1 和 MASP-3 无关。
Clin Exp Immunol. 2014 Apr;176(1):84-92. doi: 10.1111/cei.12244.
5
Complement factor D in age-related macular degeneration.补体因子 D 与年龄相关性黄斑变性。
Invest Ophthalmol Vis Sci. 2011 Nov 11;52(12):8828-34. doi: 10.1167/iovs.11-7933.
6
Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.甘露糖结合凝集素相关丝氨酸蛋白酶-1/3 激活补体替代途径的机制。
Mol Immunol. 2011 Oct;49(1-2):281-9. doi: 10.1016/j.molimm.2011.08.021. Epub 2011 Sep 23.
7
Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.甘露聚糖结合凝集素相关丝氨酸蛋白酶-1在补体因子 D 活化中的必需作用。
J Exp Med. 2010 Jan 18;207(1):29-37. doi: 10.1084/jem.20090633. Epub 2009 Dec 28.
8
Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells.补体因子D、白蛋白和免疫球蛋白G抗带3蛋白抗体在促进疟疾感染红细胞的玫瑰花结形成方面模拟血清。
Infect Immun. 2007 Apr;75(4):1771-7. doi: 10.1128/IAI.01514-06. Epub 2007 Jan 29.
9
Partial amino acid sequence of human factor D:homology with serine proteases.人D因子的部分氨基酸序列:与丝氨酸蛋白酶的同源性
Proc Natl Acad Sci U S A. 1980 Feb;77(2):1116-9. doi: 10.1073/pnas.77.2.1116.
10
Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.人补体替代途径的D因子。主要溴化氰片段的纯化、比对及N端氨基酸序列,以及活性位点丝氨酸残基的定位
Biochem J. 1980 Jun 1;187(3):863-74. doi: 10.1042/bj1870863.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
3
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
4
A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.超敏反应和移植免疫中免疫抑制的新概念。
Surv Ophthalmol. 1966 Aug;11(4):498-505.
5
Plasminogen: purification from human plasma by affinity chromatography.纤溶酶原:通过亲和色谱法从人血浆中纯化。
Science. 1970 Dec 4;170(3962):1095-6. doi: 10.1126/science.170.3962.1095.
6
Functional relationship of factor B in the properdin system to C3 proactivator of human serum.备解素系统中B因子与人血清C3前活化剂的功能关系。
J Immunol. 1971 Oct;107(4):1200-4.
7
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.眼镜蛇毒中的两种抗补体因子:其中一种可使豚鼠红细胞发生溶血。
J Immunol. 1969 Nov;103(5):944-52.
8
Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.参与眼镜蛇毒因子依赖性补体激活的衰变和再生过程的血清蛋白。
J Immunol. 1973 Dec;111(6):1730-6.
9
Formation and function of a complex of the C3 proactivator with a protein from cobra venom.补体3前活化剂与眼镜蛇毒蛋白复合物的形成及功能
J Exp Med. 1973 Feb 1;137(2):451-60. doi: 10.1084/jem.137.2.451.
10
The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.富含甘氨酸的糖蛋白与备解素系统中的B因子以及人血清眼镜蛇因子结合蛋白的关系。
J Exp Med. 1973 Feb 1;137(2):424-37. doi: 10.1084/jem.137.2.424.

备解素因子D:其活性位点的表征及前体形式的分离。

Properdin factor D: characterization of its active site and isolation of the precursor form.

作者信息

Fearon D T, Austen K F, Ruddy S

出版信息

J Exp Med. 1974 Feb 1;139(2):355-66. doi: 10.1084/jem.139.2.355.

DOI:10.1084/jem.139.2.355
PMID:4855753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2139519/
Abstract

The activity of properdin factor D was measured by the generation of the hemolytically active cellular intermediate, EAC43B(D), bearing the C3b-dependent alternate pathway C3 convertase. Treatment of factor D with DFP prevented formation of EAC43B(D); thus, a serine esterase is essential for the generation of the alternate pathway C3 convertase, a situation analogous to the role of C1 in the formation of the classical C3 convertase, C42. The definition of factor D as a serine esterase prompted a search for its proenzyme form, and resulted in the chromatographic isolation from plasma of a single peak of trypsin-inducible factor D activity, distinct from activated factor D. Analytical gel filtration indicated an apparent mol wt of 25,000. This protein from which trypsin elaborated factor D activity, as assessed by the formation of EAC43B(D), the generation of the CoVF-dependent C3 convertase, and the cleavage of factor B in the presence of C3b, was designated "precursor factor D." The DFP resistance of precursor factor D, and the susceptibility of its trypsin-activated form to inactivation by DFP is analogous to the behavior of other plasma serine esterases, including C1.

摘要

通过产生具有溶血活性的细胞中间体EAC43B(D)来测定备解素因子D的活性,该中间体带有依赖C3b的替代途径C3转化酶。用二异丙基氟磷酸(DFP)处理因子D可阻止EAC43B(D)的形成;因此,丝氨酸酯酶对于替代途径C3转化酶的产生至关重要,这种情况类似于C1在经典C3转化酶C42形成中的作用。将因子D定义为丝氨酸酯酶促使人们寻找其酶原形式,并从血浆中通过色谱法分离出一个单一的胰蛋白酶诱导因子D活性峰,它与活化的因子D不同。分析性凝胶过滤表明其表观分子量为25,000。通过EAC4B(D)的形成、依赖C3转化酶前体因子(CoVF)的C3转化酶的产生以及在C3b存在下因子B的裂解来评估,这种经胰蛋白酶作用产生因子D活性的蛋白质被命名为“前体因子D”。前体因子D对DFP具有抗性,而其经胰蛋白酶激活的形式对DFP灭活敏感,这类似于其他血浆丝氨酸酯酶(包括C1)的行为。